Dan Su

4.7k total citations
139 papers, 2.7k citations indexed

About

Dan Su is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Dan Su has authored 139 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Oncology, 48 papers in Molecular Biology and 38 papers in Cancer Research. Recurrent topics in Dan Su's work include Cancer Genomics and Diagnostics (17 papers), Pancreatic and Hepatic Oncology Research (15 papers) and Lung Cancer Treatments and Mutations (13 papers). Dan Su is often cited by papers focused on Cancer Genomics and Diagnostics (17 papers), Pancreatic and Hepatic Oncology Research (15 papers) and Lung Cancer Treatments and Mutations (13 papers). Dan Su collaborates with scholars based in China, United States and Italy. Dan Su's co-authors include Lisha Ying, Weimin Mao, Liming Sheng, Jianguo Feng, Herbert Yu, Junzhou Wu, Fanrong Zhang, Pengjun Zhao, Hao Jiang and Kaiyan Chen and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Dan Su

129 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dan Su China 32 1.4k 993 795 571 304 139 2.7k
José Alejandro Pérez Fidalgo Spain 27 1.3k 0.9× 1.4k 1.4× 853 1.1× 569 1.0× 198 0.7× 136 2.9k
Hong Qiu China 26 1.2k 0.9× 802 0.8× 680 0.9× 370 0.6× 218 0.7× 116 2.3k
Ayumu Taguchi United States 30 1.5k 1.1× 884 0.9× 881 1.1× 551 1.0× 518 1.7× 62 2.8k
Seema Sethi United States 33 1.9k 1.4× 957 1.0× 1.2k 1.6× 614 1.1× 271 0.9× 90 3.1k
Minhua Zheng China 28 1.6k 1.2× 716 0.7× 771 1.0× 350 0.6× 252 0.8× 92 2.6k
Michalis Liontos Greece 26 1.5k 1.1× 889 0.9× 469 0.6× 359 0.6× 184 0.6× 125 2.7k
Xiaoqun Dong United States 34 1.5k 1.1× 852 0.9× 998 1.3× 264 0.5× 374 1.2× 84 2.7k
Jinglin Xia China 30 1.2k 0.9× 694 0.7× 702 0.9× 463 0.8× 375 1.2× 107 2.8k

Countries citing papers authored by Dan Su

Since Specialization
Citations

This map shows the geographic impact of Dan Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Su more than expected).

Fields of papers citing papers by Dan Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Su. The network helps show where Dan Su may publish in the future.

Co-authorship network of co-authors of Dan Su

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Su. A scholar is included among the top collaborators of Dan Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Su. Dan Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Su, Dan, et al.. (2024). Enhancing polycyclic aromatic hydrocarbon soil remediation in cold climates using immobilized low-temperature-resistant mixed microorganisms. The Science of The Total Environment. 939. 173414–173414. 4 indexed citations
4.
Wang, Yingzhi, Xiaoqian Ren, Tao Li, Dan Su, & Rundong Zhang. (2024). Crystal structure and function analysis of 6-phosphogluconate dehydrogenase in Mycobacterium tuberculosis. Biochemical and Biophysical Research Communications. 731. 150390–150390.
5.
6.
Ying, Lisha, et al.. (2024). The distribution of the extrachromosomal DNA molecules in early lung cancer. Science Progress. 107(3). 342247267–342247267. 1 indexed citations
8.
Xu, Kai, Jingxuan Wei, Dan Su, et al.. (2024). Cost-effectiveness of tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma: a comparative analysis in China, the United States and Europe. International Journal of Clinical Pharmacy. 47(1). 196–209. 1 indexed citations
9.
Su, Dan, Hongyu Yang, Qiu Chen, & Yue Chen. (2023). Peptide receptor radionuclide therapy in advanced Pheochromocytomas and Paragangliomas: a systematic review and meta-analysis. Frontiers in Oncology. 13. 1141648–1141648. 4 indexed citations
10.
Zhang, Bin, Xiaofeng Guo, Leyi Huang, et al.. (2023). Tumour-associated macrophages and Schwann cells promote perineural invasion via paracrine loop in pancreatic ductal adenocarcinoma. British Journal of Cancer. 130(4). 542–554. 34 indexed citations
11.
Wu, Huanwen, Zicheng Yu, Yueping Liu, et al.. (2022). Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract. Cancer Communications. 42(12). 1367–1386. 23 indexed citations
12.
Shang, Jingjing, et al.. (2021). Impact of antibiotic prophylaxis courses on postoperative complications following total joint arthroplasty: Finding from Chinese population. Journal of Clinical Pharmacy and Therapeutics. 47(1). 61–69.
13.
Li, Junjie, Jing Wang, Dan Su, et al.. (2021). p53 Immunohistochemistry Patterns Are Surrogate Biomarkers for TP53 Mutations in Gastrointestinal Neuroendocrine Neoplasms. Gastroenterology Research and Practice. 2021. 1–9. 15 indexed citations
14.
Feng, Tingting, Yan Zhang, Sunbin Ling, et al.. (2021). PDZ Binding Kinase/T-LAK Cell-Derived Protein Kinase Plays an Oncogenic Role and Promotes Immune Escape in Human Tumors. Journal of Oncology. 2021. 1–16. 6 indexed citations
15.
Luo, Qingyu, Xiaowei Wu, Pengfei Zhao, et al.. (2021). OTUD1 Activates Caspase‐Independent and Caspase‐Dependent Apoptosis by Promoting AIF Nuclear Translocation and MCL1 Degradation. Advanced Science. 8(8). 2002874–2002874. 55 indexed citations
16.
Luo, Qingyu, Xiaowei Wu, Wan Chang, et al.. (2019). ARID1A prevents squamous cell carcinoma initiation and chemoresistance by antagonizing pRb/E2F1/c-Myc-mediated cancer stemness. Cell Death and Differentiation. 27(6). 1981–1997. 35 indexed citations
17.
Yin, Wenjuan, Jiaoyue Jin, Canming Wang, Dan Su, & Xianghou Xia. (2019). Analysis of pathological features of epstein-barr virus-associated gastric cancer and exploration of the role of radical gastrectomy in its clinical prognosis. Zhonghua shiyan waike zazhi. 36(6). 1107–1109. 1 indexed citations
18.
Luo, Aiping, Xuantong Zhou, Xing Shi, et al.. (2019). Exosome-derived miR-339-5p mediates radiosensitivity by targeting Cdc25A in locally advanced esophageal squamous cell carcinoma. Oncogene. 38(25). 4990–5006. 108 indexed citations
19.
Xue, Yue, Lihua Lai, Wenwen Lian, et al.. (2018). SOX9/FXYD3/Src Axis Is Critical for ER+ Breast Cancer Stem Cell Function. Molecular Cancer Research. 17(1). 238–249. 43 indexed citations
20.
Jin, Ying, Guangyun Mao, Yaping Wei, et al.. (2016). CYFRA 21-1 is an early predictor of chemotherapeutic effectiveness in advanced nonsmall cell lung cancer. Medicine. 95(52). e5748–e5748. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026